Swedencare AB (publ) Share Price Nasdaq Stockholm
Equities
SE0008294078
Pharmaceuticals
Sales 2024 * | 2.66B 246M 19.6B | Sales 2025 * | 3B 277M 22.1B | Capitalization | 8.99B 831M 66.26B |
---|---|---|---|---|---|
Net income 2024 * | 228M 21.08M 1.68B | Net income 2025 * | 343M 31.72M 2.53B | EV / Sales 2024 * | 3.76 x |
Net Debt 2024 * | 1B 92.51M 7.37B | Net Debt 2025 * | 488M 45.12M 3.6B | EV / Sales 2025 * | 3.16 x |
P/E ratio 2024 * |
39.5
x | P/E ratio 2025 * |
26.2
x | Employees | - |
Yield 2024 * |
0.88% | Yield 2025 * |
1.41% | Free-Float | 35.04% |
Latest transcript on Swedencare AB (publ)
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 31/12/13 | |
Jenny Graflind
DFI | Director of Finance/CFO | 48 | 31/12/16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 65 | 31/12/22 | |
Director/Board Member | 57 | 31/12/15 | |
Director/Board Member | 61 | 31/12/18 |
1st Jan change | Capi. | |
---|---|---|
-15.35% | 76.23B | |
-9.19% | 6.67B | |
-1.11% | 3.21B | |
+6.08% | 1.52B | |
-15.13% | 1.37B | |
-25.63% | 1.24B | |
-7.62% | 1.21B | |
-10.84% | 1.17B | |
-.--% | 1.05B |